Skip to main content

ExodusPoint Capital Management, LP

Position in VKTX — Viking Therapeutics, Inc.

CIK 1736225 NEW YORK, NY

Position in VKTX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,265,662
-$23,141,298 QoQ
Shares Held
69,627
-90.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Mar 31, 2026
CallValue
$4,461,234
CallShares
137,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. VKTX ranks #46 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,461,234 137,100
2026-03-31 $2,265,662 69,627
2025-12-31 $11,482,752 326,400
2025-12-31 $25,406,960 722,199
2025-09-30 $5,366,113 204,190
2025-09-30 $525,600 20,000
2025-06-30 $530,000 20,000
2025-06-30 $1,025,974 38,716
2025-03-31 $8,447,911 349,810
2025-03-31 $483,000 20,000
2024-12-31 $12,647,432 314,300
2024-12-31 $9,476,640 235,503
2024-09-30 $16,660,596 263,159
2024-09-30 $9,566,141 151,100
2024-06-30 $2,805,819 52,930
2024-06-30 $14,551,245 274,500
2024-03-31 $2,410,800 29,400
2024-03-31 $1,155,790 14,095
2023-12-31 $1,262,297 67,829
2022-09-30 $83,648 30,753
2022-06-30 $70,056 24,241
2021-09-30 $153,263 24,405
2021-06-30 $453,083 75,640
2021-03-31 $374,964 59,283
2020-06-30 $190,841 26,469